Robert Hiscox (26 results)

Hardcover. Condition: New. US SELLER SHIPS FAST FROM USA.

hardcover. Condition: Very Good. John Virtue (illustrator). National Gallery Company (Yale University Press); London (New Haven), 2005. Hardcover. A Very Good, grey cloth binding with black and white lettering on front board and spine, binding sturdy and intact, trace handling marks, some scattered foxing to text block edges, in a Very Good, trace handling/scuff marks to panels, bit of edge/corner wear, soiled spot bottom front panel, small soiled stain bottom rear panel edge and verso, Dust wrapper. A nice, clean and unmarked copy. 8vo[octavo or approx. 6 x 9 inches]. 112pp., b&w illustrations. We pack securely and ship daily with delivery confirmation on every book. The picture on the listing page is of the actual book for sale. Additional Scan(s) are available for any item, please inquire.Please note: Oversized books/sets MAY require additional postage then what is quoted for 2.2lb book.

Paperback. Condition: Near Fine. 1996. Nice Firm Clean copy ! Unmarked. Unpaginated pages. All illustrated with brilliant full-page color potography. A collection of twentieth century painting and sculpture collected for the offices of The Hiscox Insurance Company - mostly British, but including a group of works by the Russian Revolutionary avant garde. The collection ranges from Sickert and Camden Town, Bomberg, Nicholson, Hepworth, and Moore, Kossoff and Auerbach, Bacon and Freud, through to Damien Hirst, Mark Francis, and other contemporary artists. 7259L.

Card Covers. Condition: Very Good. First Edition. 108 pages, colour illustrations. Artists include Roderic O'Conor; W R Sickert; Mark Gertler; Rembrandt Bugatti; Jacob Epstein, Robert Michel; Barbara Hepworth; David Bomberg; R Bertelli; Edawrd Burra; Henry Moore; Ben Nicholson; Oscar Nemon; Francis Bacon; Ivon Hitchens; Peter Lanyon; Frank Auerbach; Leon Kossoff; Fred Williams; Lucian Freud; Bill Jacklin; Mary Newcombe; Gilbert & George; Christo; June Redfern; John Wonnacott; Jennifer Wood; Therese Oulton; Stephen Contoy; Peter Prendegast; Matthew Radford; Mark Francis; Richard Billingham; Sarah Raphael; Nina Murdoch; Louise Butler-Adams; Jason Gathorne-Hardy; Julie Roberts; Brad Lochore; Damien Hirst; Ian Davenport. Minor wear to covers, contents fine. [722] Size: 255mm. x 210mm. Book.

hardcover. Condition: New. John Virtue (illustrator). In shrink wrap. Looks like an interesting title!

Condition: New. In.

Condition: New. In.

Condition: New. pp. 212.

Condition: New. pp. 212 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.

Condition: New. pp. 212.

Taschenbuch. Condition: Neu. Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer | New Molecular Aspects and their Potential as Targets | Stephen Hiscox (u. a.) | Taschenbuch | xii | Englisch | 2010 | Springer | EAN 9789048179015 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens. Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.

Buch. Condition: Neu. Neuware -One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 212 pp. Englisch.

Taschenbuch. Condition: Neu. Neuware -One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 212 pp. Englisch.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.

Hardcover. Condition: Like New. Like New. book.

Hardcover. Condition: Brand New. 1st edition. 198 pages. 9.50x6.25x0.25 inches. In Stock.

Hardcover. Condition: As New. 1st Edition. 4° - Color Plates. Published as Exhibition Catalogue: Works from Damien Hirst's murderme Collection at Serpentine Gallery London November 2006 to January 2007 F. Bacon, Banksy, Don Brown, A. Bulloch, John Curtin, A. Fairhurst, Tracey Emin, S. Gregory, M. Harvey, Rachel Howard, J. Isaacs, Michael Joo, Jeff Koons, Jim Lambie, S. Sanders, Tim Lewis, N. Lumb, Sarah Lucas, Tom Ormond, L. Owen, Richard Prince, Haim Steinbach, G. Turk & Andy Warhol. Text in English. Original Binding. As New.

2009, 175 pp.,plates and ill. m184.

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike. 212 pp. Englisch.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike. 212 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Presents a clear and in-depth overview of both the clinical and scientific aspects of endocrine resistance in breast cancerIncludes emerging and novel themes in breast cancer resistance developmentReports up-to-date scientific and translati.

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Presents a clear and in-depth overview of both the clinical and scientific aspects of endocrine resistance in breast cancerIncludes emerging and novel themes in breast cancer resistance developmentReports up-to-date scientific and translati.

Buch. Condition: Neu. Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer | New Molecular Aspects and their Potential as Targets | Stephen Hiscox (u. a.) | Buch | xii | Englisch | 2009 | Springer | EAN 9781402085253 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.